Nele Brusselaers1, Sonia Labeau, Dirk Vogelaers, Stijn Blot. 1. Department of Internal Medicine, Infectious Diseases and Psychosomatic Medicine, Ghent University Hospital, de Pintelaan 185, 9000 Ghent, Belgium. nele.brusselaers@ki.se
Abstract
PURPOSE: In ventilator-associated pneumonia (VAP), early appropriate antimicrobial therapy may be hampered by involvement of multidrug-resistant (MDR) pathogens. METHODS: A systematic review and diagnostic test accuracy meta-analysis were performed to analyse whether lower respiratory tract surveillance cultures accurately predict the causative pathogens of subsequent VAP in adult patients. Selection and assessment of eligibility were performed by three investigators by mutual consideration. Of the 525 studies retrieved, 14 were eligible for inclusion (all in English; published since 1994), accounting for 791 VAP episodes. The following data were collected: study and population characteristics; in- and exclusion criteria; diagnostic criteria for VAP; microbiological workup of surveillance and diagnostic VAP cultures. Sub-analyses were conducted for VAP caused by Staphylococcus aureus, Pseudomonas spp., and Acinetobacter spp., MDR microorganisms, frequency of sampling, and consideration of all versus the most recent surveillance cultures. RESULTS: The meta-analysis showed a high accuracy of surveillance cultures, with pooled sensitivities up to 0.75 and specificities up to 0.92 in culture-positive VAP. The area under the curve (AUC) of the hierarchical summary receiver-operating characteristic curve demonstrates moderate accuracy (AUC: 0.90) in predicting multidrug resistance. A sampling frequency of >2/week (sensitivity 0.79; specificity 0.96) and consideration of only the most recent surveillance culture (sensitivity 0.78; specificity 0.96) are associated with a higher accuracy of prediction. CONCLUSIONS: This study provides evidence for the benefit of surveillance cultures in predicting MDR bacterial pathogens in VAP. However, clinical and statistical heterogeneity, limited samples sizes, and bias remain important limitations of this meta-analysis.
PURPOSE: In ventilator-associated pneumonia (VAP), early appropriate antimicrobial therapy may be hampered by involvement of multidrug-resistant (MDR) pathogens. METHODS: A systematic review and diagnostic test accuracy meta-analysis were performed to analyse whether lower respiratory tract surveillance cultures accurately predict the causative pathogens of subsequent VAP in adult patients. Selection and assessment of eligibility were performed by three investigators by mutual consideration. Of the 525 studies retrieved, 14 were eligible for inclusion (all in English; published since 1994), accounting for 791 VAP episodes. The following data were collected: study and population characteristics; in- and exclusion criteria; diagnostic criteria for VAP; microbiological workup of surveillance and diagnostic VAP cultures. Sub-analyses were conducted for VAP caused by Staphylococcus aureus, Pseudomonas spp., and Acinetobacter spp., MDR microorganisms, frequency of sampling, and consideration of all versus the most recent surveillance cultures. RESULTS: The meta-analysis showed a high accuracy of surveillance cultures, with pooled sensitivities up to 0.75 and specificities up to 0.92 in culture-positive VAP. The area under the curve (AUC) of the hierarchical summary receiver-operating characteristic curve demonstrates moderate accuracy (AUC: 0.90) in predicting multidrug resistance. A sampling frequency of >2/week (sensitivity 0.79; specificity 0.96) and consideration of only the most recent surveillance culture (sensitivity 0.78; specificity 0.96) are associated with a higher accuracy of prediction. CONCLUSIONS: This study provides evidence for the benefit of surveillance cultures in predicting MDR bacterial pathogens in VAP. However, clinical and statistical heterogeneity, limited samples sizes, and bias remain important limitations of this meta-analysis.
Authors: Kevin M Sanders; Neill K J Adhikari; Jan O Friedrich; Andrew Day; Xuran Jiang; Daren Heyland Journal: J Crit Care Date: 2008-03 Impact factor: 3.425
Authors: Mariska M G Leeflang; Jonathan J Deeks; Constantine Gatsonis; Patrick M M Bossuyt Journal: Ann Intern Med Date: 2008-12-16 Impact factor: 25.391
Authors: P Depuydt; D Benoit; D Vogelaers; J Decruyenaere; D Vandijck; G Claeys; G Verschraegen; S Blot Journal: Intensive Care Med Date: 2007-12-08 Impact factor: 17.440
Authors: L Lampati; E Maggioni; M Langer; P Malacarne; R Mozzo; A Pesenti; R Fumagalli Journal: Minerva Anestesiol Date: 2009-05-21 Impact factor: 3.051
Authors: S Roisin; T-D Huang; R de Mendonça; C Nonhoff; P Bogaerts; M Hites; B Delaere; S Hamels; F de Longueville; Y Glupczynski; O Denis Journal: Eur J Clin Microbiol Infect Dis Date: 2017-09-27 Impact factor: 3.267
Authors: Johannes B J Scholte; Helke A van Dessel; Catharina F M Linssen; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook Journal: J Clin Microbiol Date: 2014-07-30 Impact factor: 5.948
Authors: Ivor S Douglas; Connie S Price; Katherine H Overdier; Robert F Wolken; Steven W Metzger; Kenneth R Hance; David C Howson Journal: Am J Respir Crit Care Med Date: 2015-03-01 Impact factor: 21.405
Authors: Brendan J Kelly; Ize Imai; Kyle Bittinger; Alice Laughlin; Barry D Fuchs; Frederic D Bushman; Ronald G Collman Journal: Microbiome Date: 2016-02-11 Impact factor: 14.650
Authors: Liesbet De Bus; Lies Saerens; Bram Gadeyne; Jerina Boelens; Geert Claeys; Jan J De Waele; Dominique D Benoit; Johan Decruyenaere; Pieter O Depuydt Journal: Crit Care Date: 2014-07-15 Impact factor: 9.097
Authors: J B J Scholte; H L Duong; C Linssen; H Van Dessel; D Bergmans; R van der Horst; P Savelkoul; P Roekaerts; W van Mook Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-18 Impact factor: 3.267